A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.

Inclusion Criteria: * Healthy adults between 19 and 50 years of age * People with a body weight within a healthy range * People who do not have serious medical conditions and have been generally healthy in recent years * People whose screening tests (blood tests, urine tests, vital signs, ECG, etc.) show no significant abnormalities * Women of childbearing potential must not be pregnant at screening * Participants must agree to use reliable contraception or abstain from sexual activity during the study and for a short period after the last dose * People who fully understand the study, agree to follow study requirements, and provide written informed consent Exclusion Criteria: * People with a history of significant diseases, such as heart, liver, kidney, lung, neurological, psychiatric, immune, or cancer-related conditions * People with digestive diseases or surgeries that may affect how medicines are absorbed * People with abnormal screening laboratory results, especially related to liver or kidney function * People who drink large amounts of alcohol, use drugs, or smoke heavily * People who have recently taken certain medications, herbal products, or dietary supplements that could interfere with the study * People who have recently participated in another clinical trial, donated blood, or received a blood transfusion * Pregnant or breastfeeding women * People with unstable or serious health conditions that could increase risk or affect study results * Anyone who, in the opinion of the study doctor, is not suitable to participate